Director/PDMR Shareholding

RNS Number : 8595E

GlaxoSmithKline PLC

13 April 2011

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 April 2011 of an increase in their notional interests in Ordinary shares at a price of £12.22 per share and ADRs at a price of $39.96 per ADR following the notional re-investment of the dividend paid to shareholders on 7 April 2011.

	Ordinary shares	ADRs
Mr A P Witty	5097.75
Dr M M Slaoui		1219.01
Mr S M Bicknell	158.12
Mr J M Clarke	1371.08
Mr M Dunoyer	516.38
Mr E J Gray	890.31
Mr S A Hussain	790.64
Mr W C Louv		441.67
Dr D Pulman		441.67
Mr D S Redfern	210.11
Mr J R Stéphenne	473.65
Ms C Thomas	158.12
Mr D E Troy		984.75
Dr P J T Vallance	652.78
Mrs V A Whyte	37.75

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

V A Whyte

Company Secretary

13 April 2011

 

END

 

 

RDSXXLFFFZFZBBF